The COVID-19 vaccination rate was 62% in urban and 52% in rural communities, with most of the study participants vaccinated with adenoviral-vectored vaccines encoding the Wuhan-Hu-1 CoV-2 Spike protein (AstraZeneca or Johnson&Johnson) and fewer with Wuhan-Hu-1 Spike mRNA vaccines (PfizerBioNTech or Moderna) (Figure 1E). Here, CHMP5 is linked to COVID-19.